RxSight Inc (NAS:RXST)
$ 56.45 2.12 (3.9%) Market Cap: 2.24 Bil Enterprise Value: 2.02 Bil PE Ratio: 0 PB Ratio: 8.13 GF Score: 58/100

Rxsight Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 10:55PM GMT
Release Date Price: $21.15 (+9.87%)
Craig William Bijou
BofA Securities, Research Division - Research Analyst

Craig Bijou, medical device analyst for BofA. And it's a pleasure to have RxSight here, and from the company, Ron Kurtz, CEO; and Shelley Thunen, CFO. So Ron, Shelley, thank you for coming.

Shelley B. Thunen
RxSight, Inc. - CFO & Assistant Secretary

Thank you very much for having us.

Craig William Bijou
BofA Securities, Research Division - Research Analyst

So it's a bit of an abbreviated fireside chat, so I kind of want to hit on the hot topics.

Questions & Answers

Craig William Bijou;
BofA Securities, Research Division - Research Analyst

ASCRS obviously happened last weekend. And from what we've heard, there was a lot of buzz around you guys. So would just love to hear your feedback from the conference, what the feedback from docs were? How does that compare to prior year conferences? And is there an acceleration in interest in you guys and in your technology?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot